BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16261413)

  • 1. Estrogen receptor beta (ESR2) polymorphisms in familial and sporadic breast cancer.
    Maguire P; Margolin S; Skoglund J; Sun XF; Gustafsson JA; Børresen-Dale AL; Lindblom A
    Breast Cancer Res Treat; 2005 Nov; 94(2):145-52. PubMed ID: 16261413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique ESR1 and ESR2 estrogen receptor gene variants associated with altered risk of triple-negative breast cancer: A case-control study.
    Sghaier I; Zidi S; El-Ghali RM; Daldoul A; Aimagambetova G; Almawi WY
    Gene; 2023 Jan; 851():146969. PubMed ID: 36261089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential association of ESR1 and ESR2 gene variants with the risk of breast cancer and associated features: A case-control study.
    Ghali RM; Al-Mutawa MA; Al-Ansari AK; Zaied S; Bhiri H; Mahjoub T; Almawi WY
    Gene; 2018 Apr; 651():194-199. PubMed ID: 29414691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review of the relationship between polymorphic sites in the estrogen receptor-beta (ESR2) gene and breast cancer risk.
    Yu KD; Rao NY; Chen AX; Fan L; Yang C; Shao ZM
    Breast Cancer Res Treat; 2011 Feb; 126(1):37-45. PubMed ID: 20390341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No association between estrogen receptor beta polymorphisms and uterine leiomyoma.
    Zhai XD; Ye Y; Yang Y; Wang Z; Mo YN
    DNA Cell Biol; 2009 Dec; 28(12):633-6. PubMed ID: 19715484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy.
    MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
    Int J Cancer; 2010 Jun; 126(12):2935-46. PubMed ID: 19739075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of estrogen receptor-beta (ESR2) polymorphism and cancer risk: a meta-analysis.
    Xia W; Wang T; Sun D; Mao W; Xie X
    Eur J Gynaecol Oncol; 2016 Aug; 37(4):530-538. PubMed ID: 29894079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variants of estrogen receptor alpha and beta genes modify the severity of sporadic breast cancer.
    Rezende LM; Marson FA; Lima CS; Bertuzzo CS
    Gene; 2017 Apr; 608():73-78. PubMed ID: 28109853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.
    Chen YC; Kraft P; Bretsky P; Ketkar S; Hunter DJ; Albanes D; Altshuler D; Andriole G; Berg CD; Boeing H; Burtt N; Bueno-de-Mesquita B; Cann H; Canzian F; Chanock S; Dunning A; Feigelson HS; Freedman M; Gaziano JM; Giovannucci E; Sánchez MJ; Haiman CA; Hallmans G; Hayes RB; Henderson BE; Hirschhorn J; Kaaks R; Key TJ; Kolonel LN; LeMarchand L; Ma J; Overvad K; Palli D; Pharaoh P; Pike M; Riboli E; Rodriguez C; Setiawan VW; Stampfer M; Stram DO; Thomas G; Thun MJ; Travis RC; Virtamo J; Trichopoulou A; Wacholder S; Weinstein SJ
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):1973-81. PubMed ID: 17932344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer.
    Tsezou A; Tzetis M; Gennatas C; Giannatou E; Pampanos A; Malamis G; Kanavakis E; Kitsiou S
    Breast; 2008 Apr; 17(2):159-66. PubMed ID: 17904846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haplotypes of the estrogen receptor beta gene and breast cancer risk.
    ; Cox DG; Bretsky P; Kraft P; Pharoah P; Albanes D; Altshuler D; Amiano P; Berglund G; Boeing H; Buring J; Burtt N; Calle EE; Canzian F; Chanock S; Clavel-Chapelon F; Colditz GA; Feigelson HS; Haiman CA; Hankinson SE; Hirschhorn J; Henderson BE; Hoover R; Hunter DJ; Kaaks R; Kolonel L; LeMarchand L; Lund E; Palli D; Peeters PH; Pike MC; Riboli E; Stram DO; Thun M; Tjonneland A; Travis RC; Trichopoulos D; Yeager M
    Int J Cancer; 2008 Jan; 122(2):387-92. PubMed ID: 17935138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microsatellites in the estrogen receptor (ESR1, ESR2) and androgen receptor (AR) genes and breast cancer risk in African American and Nigerian women.
    Zheng Y; Huo D; Zhang J; Yoshimatsu TF; Niu Q; Olopade OI
    PLoS One; 2012; 7(7):e40494. PubMed ID: 22792352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms in the promoter region of ESR2 gene and breast cancer susceptibility.
    Treeck O; Elemenler E; Kriener C; Horn F; Springwald A; Hartmann A; Ortmann O
    J Steroid Biochem Mol Biol; 2009 Apr; 114(3-5):207-11. PubMed ID: 19429453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.
    Leyland-Jones B; Gray KP; Abramovitz M; Bouzyk M; Young B; Long B; Kammler R; Dell'Orto P; Biasi MO; Thürlimann B; Harvey V; Neven P; Arnould L; Maibach R; Price KN; Coates AS; Goldhirsch A; Gelber RD; Pagani O; Viale G; Rae JM; Regan MM;
    Breast Cancer Res Treat; 2015 Dec; 154(3):543-55. PubMed ID: 26590813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in the ESR1 and ESR2 genes and genetic susceptibility to anorexia nervosa.
    Eastwood H; Brown KM; Markovic D; Pieri LF
    Mol Psychiatry; 2002; 7(1):86-9. PubMed ID: 11803451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.
    Fu C; Dong WQ; Wang A; Qiu G
    Tumour Biol; 2014 Aug; 35(8):8319-28. PubMed ID: 24859835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic polymorphisms of estrogen receptors alpha and beta and the risk of developing prostate cancer.
    Chae YK; Huang HY; Strickland P; Hoffman SC; Helzlsouer K
    PLoS One; 2009 Aug; 4(8):e6523. PubMed ID: 19654868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
    Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
    J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor 2 gene polymorphism in idiopathic scoliosis.
    Kotwicki T; Janusz P; Andrusiewicz M; Chmielewska M; Kotwicka M
    Spine (Phila Pa 1976); 2014 Dec; 39(26):E1599-607. PubMed ID: 25341980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of genetic variants in Estrogen receptor (ESR)1 and ESR2 with susceptibility to recurrent pregnancy loss in Tunisian women: A case control study.
    Bahia W; Soltani I; Haddad A; Soua A; Radhouani A; Mahdhi A; Ferchichi S
    Gene; 2020 Apr; 736():144406. PubMed ID: 32007580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.